
HIV infection, Transplant-related infectious diseases, general infectious diseases, Biological and Emergency Preparedness for hospital systems, influenza and respiratory viral pathogens
Education and Training
- Fellow in Infectious Diseases, Medicine, Duke University, 2007 - 2008
- M.B.B.S., University of Melbourne (Australia), 2000
Grants
- Ph IIa, randomized, double blind placebo controlled trial of EIDD-2801 to eliminate COVID Viral RNA detection
- Transplant Infectious Diseases Interdisciplinary Research Training Grant (TIDIRTG)
- CISA 07 Adult RCT COVID-19 Vaccination (Lead)
- DAS181-3-01
- Adaptive COVID-19 Treatment Trial (ACTT)
- ACTIV1: Master Protocol for Immune Modulars: Remdisivir in COVID 19 patients
- CARE Focus 1: Latency Biomarker Project
- CMV Quant Assay
- Phase III, Remdesivir (GS-5734) in severe COVID-19 participants
- Phase III study of Remdesivir in Moderate COVID-19 patients